LESS NETWORK LEAKAGE, BETTER PATIENT CARE
We founded Fibroblast in 2011 after learning of a tragic story about a missed cancer diagnosis because of poor referral management between providers. Fibroblast’s mission is to improve the referral process to ensure that no patient falls through a crack in the healthcare system and misses out on potentially lifesaving care. We take our company name from a cell in the body that forms connective tissues and plays a critical role in the body’s healing process.
Co-Founder & Chief Executive Officer
As CEO, Scott leads Fibroblast’s strategy, business development, sales, and customer success efforts, among other things. Scott is deeply committed to Fibroblast’s mission of ensuring that no patient falls through a crack in the healthcare system, and he is passionate about healthcare innovation and reform. Scott regularly presents on topics including enterprise leakage reduction, healthcare information technology innovation, entrepreneurial selling, venture and angel financing, Customer Development and Lean Startup methodologies, and entrepreneurship. Prior to co-founding Fibroblast, Scott was a senior commercial litigation associate with an AmLaw 100 law firm, serving as trial counsel for Fortune 100 companies and national financial service firms in state and federal courts and before the SEC, NYSE, and FINRA. Scott also served as a Managing Director of a premiere Chicago-based legal search and consultancy firm. Scott graduated from Washington University School of Law, after receiving a BA from the University of Illinois. Scott has also studied at the University of Chicago’s Booth School of Business.
ANDREW ALBERT, MD, MPH
Co-Founder & Chief Medical Officer
Gastroenterologist Dr. Andrew Albert is a clinician and medical entrepreneur with an innovative and thriving practice in Chicago. After graduating from the George Washington University School of Medicine with an MD and MPH, Andrew went on to become the Associate Chief Resident at Boston University Medical Center and a fellow at Loyola Medical Center in Chicago. He is Board Certified in Gastroenterology and Internal Medicine and has completed advanced training at The University of Chicago. In addition to running his own practice, Andrew is a Clinical Assistant Professor of Medicine in the Digestive Diseases and Nutrition Department at the University of Illinois at Chicago. He has published numerous articles and lectured extensively within the medical community.
VP of Client Success
Eric Alvarez has spent the last six years in health systems management. At the University of Chicago Medical Center, he lead the Ophthalmology, Urology and Vascular Surgery Medical groups. From here, Eric lead the surgical medical groups of Northwestern Medical Center's Bluhm Cardiovascular Institute, a top-10 center by U.S. News and World Reports. At Fibroblast, he leads all client success initiatives including the processes, procedures, and principals that drive the successful on-boarding, implementation, and adoption of the our innovative technology. Eric received part of his undergraduate education while service active duty in the United States Air Force. He received his Bachelors in Aviation Management from Southern Illinois University and his Masters in Health Systems Management from Rush University.
VP of Product
As VP of Product, Kate oversees Fibroblast’s suite of products and data solutions. Her passion for product comes from a desire to create and deliver quality user experiences that drive overall business growth. Prior to Fibroblast, Kate worked in product management at Digital Intent in Chicago. At Digital Intent, Kate led engagements with a focus on disruptive healthcare innovation including referral management, patient engagement, and medical billing optimization. Kate has a Bachelor's degree in Cognitive Neuroscience from Northwestern University.
Chief Application Architect
As Fibroblast’s lead application architect, Mark oversees the development and deployment of Fibroblast’s platform. His background and focus on stability and scalability drives Fibroblast’s industry-leading solutions. Mark oversees the development team and provides strategic direction for Fibroblast’s technology. Mark has architected a wide variety of systems before Fibroblast, including eCommerce platforms, Web-based pharmacology applications, and enterprise data warehousing software. Mark has a Bachelor’s degree from Wheaton College and a Master’s degree in Business Administration from Northern Illinois University.